H.U. Group Holdings, Inc. (TYO: 4544)
Japan
· Delayed Price · Currency is JPY
2,628.00
+50.00 (1.94%)
Jan 9, 2025, 3:45 PM JST
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 60.52B JPY in the quarter ending September 30, 2024, with 1.00% growth. This brings the company's revenue in the last twelve months to 240.39B, down -1.22% year-over-year. In the fiscal year ending March 31, 2024, H.U. Group Holdings had annual revenue of 236.95B, down -9.18%.
Revenue (ttm)
240.39B
Revenue Growth
-1.22%
P/S Ratio
0.62
Revenue / Employee
45.40M
Employees
5,295
Market Cap
149.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
Mar 31, 2020 | 188.71B | 7.30B | 4.02% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |